Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LaSRS: Methylprednisolone for Late Phase ARDS
NCT00295269Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 1997
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone in acute respiratory distress syndrome (ARDS), sponsored by National Heart, Lung, and Blood Institute. Started Mar 1997; status: completed.
02
Drugs
methylprednisolone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00295269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295269.